Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Leukocyte Biology
|
January 23, 2020
Eosinophil and mast cell Siglecs: From biology to drug target
Jeremy A O'Sullivan, Alan T Chang, Bradford A Youngblood, et al.
Molecular Aspects of Medicine
|
July 14, 2022
Siglecs in allergy and asthma
Bruce S Bochner, Jeremy A O'Sullivan, Alan T Chang, et al.
Clinical and Translational Gastroenterology
|
October 23, 2023
Determination of Optimal Eosinophil Thresholds for Diagnosis of Eosinophilic Gastritis and Duodenitis: A Pooled Analysis of 4 Prospective Studies
Evan S Dellon, Enoch Bortey, Alan T Chang, et al.
The Journal of Allergy and Clinical Immunology
|
December 26, 2021
An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria
Sabine Altrichter, Petra Staubach, Malika Pasha, et al.
The British Journal of Dermatology
|
June 8, 2023
Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial
Frank Siebenhaar, Sabine Altrichter, Hanna Bonnekoh, et al.
Cells
|
December 30, 2020
Discovery, Function, and Therapeutic Targeting of Siglec-8
Bradford A Youngblood, John Leung, Rustom Falahati, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 5, 2021
Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab
Evan S Dellon, Nirmala Gonsalves, Marc E Rothenberg, et al.
The Journal of Allergy and Clinical Immunology
|
April 7, 2022
Lirentelimab for severe and chronic forms of allergic conjunctivitis
Stephen D Anesi, Joseph Tauber, Quan Dong Nguyen, et al.
The New England Journal of Medicine
|
October 21, 2020
Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis
Evan S Dellon, Kathryn A Peterson, Joseph A Murray, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Leukocyte Biology
|
January 23, 2020
Eosinophil and mast cell Siglecs: From biology to drug target
Jeremy A O'Sullivan, Alan T Chang, Bradford A Youngblood, et al.
Molecular Aspects of Medicine
|
July 14, 2022
Siglecs in allergy and asthma
Bruce S Bochner, Jeremy A O'Sullivan, Alan T Chang, et al.
Clinical and Translational Gastroenterology
|
October 23, 2023
Determination of Optimal Eosinophil Thresholds for Diagnosis of Eosinophilic Gastritis and Duodenitis: A Pooled Analysis of 4 Prospective Studies
Evan S Dellon, Enoch Bortey, Alan T Chang, et al.
The Journal of Allergy and Clinical Immunology
|
December 26, 2021
An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria
Sabine Altrichter, Petra Staubach, Malika Pasha, et al.
The British Journal of Dermatology
|
June 8, 2023
Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial
Frank Siebenhaar, Sabine Altrichter, Hanna Bonnekoh, et al.
Cells
|
December 30, 2020
Discovery, Function, and Therapeutic Targeting of Siglec-8
Bradford A Youngblood, John Leung, Rustom Falahati, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 5, 2021
Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab
Evan S Dellon, Nirmala Gonsalves, Marc E Rothenberg, et al.
The Journal of Allergy and Clinical Immunology
|
April 7, 2022
Lirentelimab for severe and chronic forms of allergic conjunctivitis
Stephen D Anesi, Joseph Tauber, Quan Dong Nguyen, et al.
The New England Journal of Medicine
|
October 21, 2020
Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis
Evan S Dellon, Kathryn A Peterson, Joseph A Murray, et al.
Page
of 1